ReviewCells2026

Targeting Gut Microbiota, Inflammation, and Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: Therapeutic Strategies and the Emerging Role of Time-Restricted Feeding.

Sthembiso Msane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.